businesspress24.com - BIOLASE to Present at Stifel, Nicolaus & Company 2013 Jaws & Paws Conference
 

BIOLASE to Present at Stifel, Nicolaus & Company 2013 Jaws & Paws Conference

ID: 1230180

(firmenpresse) - IRVINE, CA -- (Marketwired) -- 05/23/13 -- BIOLASE, Inc. (NASDAQ: BIOL), the world's leading manufacturer and distributor of dental lasers, announced today that Fred Furry, Chief Financial Officer, will participate in the Stifel, Nicolaus & Company 2013 Jaws & Paws Conference on Wednesday, May 29, at 1:05 pm Eastern Time. The conference is being held at Le Parker Meridien Hotel in New York City.

About BIOLASE, Inc.
BIOLASE, Inc. is a biomedical company that develops, manufactures, and markets lasers in dentistry and medicine and also markets and distributes high-end 2D and 3D digital and CAD/CAM intraoral scanners; products that are focused on technologies that advance the practice of dentistry and . The Company's laser products incorporate over 350 patented and patent-pending technologies designed to provide biologically clinically superior performance with less pain and faster recovery times. Its imaging products provide cutting-edge technology at competitive prices to deliver the best results for dentists and patients. BIOLASE's principal are dental laser systems that perform a broad range of dental procedures, including cosmetic and complex surgical applications, and a full line of dental imaging equipment. BIOLASE has sold more than 22,500 lasers.

Other products under development address ophthalmology and other medical and consumer markets.

For updates and information on WaterLase® and laser dentistry, find BIOLASE® online at , Facebook at , Twitter at , Pinterest at , LinkedIn at , Instagram at and YouTube at .

BIOLASE® and WaterLase® are registered trademarks of BIOLASE, Inc.





For further information, please contact:
Michael Porter
Porter, LeVay & Rose, Inc.
212-564-4700




Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:



Leseranfragen:



PresseKontakt / Agentur:



drucken  als PDF  an Freund senden  New Data on Cellvizio Presented at DDW 2013 Suggests That Optical Biopsies May Help Confirm and Rule Out Pancreatic Cystic Tumors*
VentriPoint Announces Closing of Private Placement and Proposed Issuance of Shares for Debt
Bereitgestellt von Benutzer: Marketwired
Datum: 23.05.2013 - 06:30 Uhr
Sprache: Deutsch
News-ID 1230180
Anzahl Zeichen: 0

contact information:
Contact person:
Town:

IRVINE, CA


Phone:

Kategorie:

Medical Devices


Anmerkungen:


Diese Pressemitteilung wurde bisher 254 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"BIOLASE to Present at Stifel, Nicolaus & Company 2013 Jaws & Paws Conference
"
steht unter der journalistisch-redaktionellen Verantwortung von

BIOLASE, Inc. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von BIOLASE, Inc.



 

Who is online

All members: 10 591
Register today: 0
Register yesterday: 0
Members online: 0
Guests online: 413


Don't have an account yet? You can create one. As registered user you have some advantages like theme manager, comments configuration and post comments with your name.